A detailed history of Fifth Third Bancorp transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Fifth Third Bancorp holds 679,841 shares of BMY stock, worth $38.2 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares
679,841
Previous 712,454 4.58%
Holding current value
$38.2 Million
Previous $29.6 Million 18.9%
% of portfolio
0.13%
Previous 0.11%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024

SELL
$39.66 - $51.75 $1.29 Million - $1.69 Million
-32,613 Reduced 4.58%
679,841 $35.2 Million
Q2 2024

Jul 22, 2024

SELL
$40.25 - $52.99 $4.34 Million - $5.71 Million
-107,758 Reduced 13.14%
712,454 $29.6 Million
Q1 2024

Apr 23, 2024

SELL
$47.98 - $54.4 $4.62 Million - $5.23 Million
-96,201 Reduced 10.5%
820,212 $44.5 Million
Q4 2023

Jan 19, 2024

SELL
$48.48 - $57.85 $16.2 Million - $19.4 Million
-334,744 Reduced 26.75%
916,413 $47 Million
Q3 2023

Oct 31, 2023

SELL
$57.89 - $64.73 $11.1 Million - $12.4 Million
-191,467 Reduced 13.27%
1,251,157 $72.6 Million
Q2 2023

Jul 25, 2023

SELL
$63.71 - $70.74 $5.64 Million - $6.26 Million
-88,519 Reduced 5.78%
1,442,624 $92.3 Million
Q1 2023

Apr 24, 2023

SELL
$65.71 - $74.53 $1.16 Million - $1.31 Million
-17,618 Reduced 1.14%
1,531,143 $106 Million
Q4 2022

Jan 25, 2023

SELL
$68.48 - $81.09 $1.75 Million - $2.07 Million
-25,488 Reduced 1.62%
1,548,761 $0
Q3 2022

Oct 25, 2022

BUY
$0.13 - $76.84 $10,384 - $6.14 Million
79,884 Added 5.35%
1,574,249 $112 Million
Q2 2022

Aug 04, 2022

BUY
$72.62 - $79.98 $6.33 Million - $6.97 Million
87,155 Added 6.19%
1,494,365 $115 Million
Q1 2022

Apr 19, 2022

BUY
$61.48 - $73.72 $6.05 Million - $7.26 Million
98,414 Added 7.52%
1,407,210 $103 Million
Q4 2021

Feb 01, 2022

SELL
$53.63 - $62.52 $12 Million - $14 Million
-223,953 Reduced 14.61%
1,308,796 $81.6 Million
Q3 2021

Oct 15, 2021

SELL
$59.17 - $69.31 $2.1 Million - $2.46 Million
-35,454 Reduced 2.26%
1,532,749 $90.7 Million
Q2 2021

Aug 06, 2021

SELL
$61.91 - $67.42 $7.93 Million - $8.64 Million
-128,121 Reduced 7.55%
1,568,203 $105 Million
Q1 2021

May 07, 2021

SELL
$59.34 - $66.74 $5.97 Million - $6.71 Million
-100,538 Reduced 5.6%
1,696,324 $107 Million
Q4 2020

Feb 16, 2021

SELL
$57.74 - $65.43 $1.78 Million - $2.02 Million
-30,851 Reduced 1.69%
1,796,862 $111 Million
Q3 2020

Nov 09, 2020

BUY
$57.43 - $63.64 $10 Million - $11.1 Million
174,048 Added 10.52%
1,827,713 $110 Million
Q2 2020

Aug 05, 2020

BUY
$54.82 - $64.09 $234,848 - $274,561
4,284 Added 0.26%
1,653,665 $97.2 Million
Q1 2020

May 05, 2020

SELL
$46.4 - $67.43 $4.12 Million - $5.99 Million
-88,852 Reduced 5.11%
1,649,381 $91.9 Million
Q4 2019

Feb 14, 2020

BUY
$49.21 - $64.19 $20.7 Million - $27 Million
420,016 Added 31.86%
1,738,233 $112 Million
Q3 2019

Nov 14, 2019

SELL
$42.77 - $50.71 $769,346 - $912,171
-17,988 Reduced 1.35%
1,318,217 $66.8 Million
Q2 2019

Aug 07, 2019

SELL
$44.62 - $49.34 $7.7 Million - $8.52 Million
-172,666 Reduced 11.44%
1,336,205 $60.6 Million
Q1 2019

May 14, 2019

BUY
$45.12 - $53.8 $14.8 Million - $17.6 Million
327,714 Added 27.75%
1,508,871 $72 Million
Q4 2018

Feb 14, 2019

SELL
$48.76 - $63.23 $3.18 Million - $4.12 Million
-65,171 Reduced 5.23%
1,181,157 $61.4 Million
Q3 2018

Nov 14, 2018

BUY
$55.19 - $62.25 $10.5 Million - $11.9 Million
190,956 Added 18.09%
1,246,328 $77.4 Million
Q2 2018

Aug 14, 2018

BUY
$50.53 - $62.98 $1.56 Million - $1.94 Million
30,869 Added 3.01%
1,055,372 $58.4 Million
Q1 2018

May 15, 2018

BUY
$59.92 - $68.98 $1.75 Million - $2.02 Million
29,231 Added 2.94%
1,024,503 $64.8 Million
Q4 2017

Feb 14, 2018

BUY
$59.94 - $65.35 $785,034 - $855,888
13,097 Added 1.33%
995,272 $61 Million
Q3 2017

Nov 14, 2017

SELL
$55.23 - $63.74 $1.05 Million - $1.21 Million
-19,022 Reduced 1.9%
982,175 $62.6 Million
Q2 2017

Aug 11, 2017

BUY
N/A
1,001,197
1,001,197 $55.8 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $120B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Fifth Third Bancorp Portfolio

Follow Fifth Third Bancorp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fifth Third Bancorp, based on Form 13F filings with the SEC.

News

Stay updated on Fifth Third Bancorp with notifications on news.